2023 Was a tricky yr for the biopharma market, with a number of firms downsizing and restructuring their workforces to stay afloat. There are indications of Restoration, as mergers and acquisitions picked up throughout the pharmaceutical and everyday living sciences field from the latter Section of 2023 and have ongoing https://sites.google.com/view/bio-sites/blog